Sleep apnea in fragile X premutation carriers with and without FXTAS

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 156, Issue 8, 2011, Pages 923-928

  Hamlin, Alyssa ^a,b   Liu, Ying ^c   Nguyen, Danh V ^d   Tassone, Flora ^a,e   Zhang, Lin ^e,f   Hagerman, Randi J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Dalian Municipal Friendship Hospital   (China)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Fragile X associated tremor ataxia syndrome; Gait disorders ataxia; Mitochondrial disorders; Sleep apnea; Trinucleotide repeat diseases

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; MESSENGER RNA;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FRAGILE X SYNDROME; GENE EXPRESSION; GENE MUTATION; GENE PREMUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SCREENING; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SLEEP APNEA SYNDROME; TRINUCLEOTIDE REPEAT;

ADULT; AGED; AGED, 80 AND OVER; ATAXIA; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; GENETIC TESTING; HUMANS; MALE; MIDDLE AGED; RNA, MESSENGER; SLEEP APNEA SYNDROMES; TREMOR; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 80054847250     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.31237     Document Type: Article

References (39)

1. Ancoli-Israel S, Kripke DE. 1991. Prevalent sleep problems in the aged. Biofeedback Self Regul 16(4): 349-359.
2. Arocena DG, Iwahashi CK, Won N, Beilina A, Ludwig AL, Tassone F, Schwartz PH, Hagerman PJ. 2005. Induction of inclusion formation and disruption of lamin A/C structure by premutation CGG-repeat RNA in human cultured neural cells. Hum Mol Genet 14(23): 3661-3671.
3. Bacalman S, Farzin F, Bourgeois JA, Cogswell J, Goodlin-Jones BL, Gane LW, Grigsby J, Leehey MA, Tassone F, Hagerman RJ. 2006. Psychiatric phenotype of the fragile X-associated tremor/ataxia syndrome (FXTAS) in males: Newly described fronto-subcortical dementia. J Clin Psychiatry 67(1): 87-94.
4. Berry-Kravis E, Abrams L, Coffey SM, Hall DA, Greco C, Gane LW, Grigsby J, Bourgeois JA, Finucane B, Jacquemont S, Brunberg JA, Zhang L, Lin J, Tassone F, Hagerman PJ, Hagerman RJ, Leehey MA. 2007a. Fragile X-associated tremor/ataxia syndrome: Clinical features, genetics, and testing guidelines. Mov Disord 22(14): 2018-2030.
5. Berry-Kravis E, Goetz CG, Leehey MA, Hagerman RJ, Zhang L, Li L, Nguyen D, Hall DA, Tartaglia N, Cogswell J, Tassone F, Hagerman PJ. 2007b. Neuropathic features in fragile X premutation carriers. Am J Med Genet Part A 143A(1): 19-26.
6. Bourgeois JA, Seritan AL, Casillas EM, Hessl D, Schneider A, Yang Y, Kaur I, Cogswell JB, Nguyen DV, Hagerman RJ. 2011. Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers. J Clin Psychiatry 72(2): 175-182.
7. Caylak E. 2009. The genetics of sleep disorders in humans: Narcolepsy, restless legs syndrome, and obstructive sleep apnea syndrome. Am J Med Genet Part A 149A(11): 2612-2626.
8. Caylak E. 2011. The molecular genetics of sleep disorders. In: eLS.: Chichester: John Wiley & Sons, Ltd. Available at DOI: 10.1002/9780470015902.a0022434.
9. Chen Y, Tassone F, Berman RF, Hagerman PJ, Hagerman RJ, Willemsen R, Pessah IN. 2010. Murine hippocampal neurons expressing Fmr1 gene premutations show early developmental deficits and late degeneration. Hum Mol Genet 19(1): 196-208.
10. Chiang A. 2006. Obstructive sleep apnea and chronic intermittent hypoxia: A review. Chinese J Physiol 49(5): 234-243.
11. Cohen S, Masyn K, Adams J, Hessl D, Rivera S, Tassone F, Brunberg J, DeCarli C, Zhang L, Cogswell J, Loesch D, Leehey M, Grigsby J, Hagerman PJ, Hagerman R. 2006. Molecular and imaging correlates of the fragile X-associated tremor/ataxia syndrome. Neurology 67(8): 1426-1431.
12. Cooke JR, Ayalon L, Palmer BW, Loredo JS, Corey-Bloom J, Natarajan L, Liu L, Ancoli-Israel S. 2009. Sustained use of CPAP slows deterioration of cognition, sleep, and mood in patients with Alzheimer's disease and obstructive sleep apnea: A preliminary study. J Clin Sleep Med 5(4): 305-309.
13. Dempsey JA, Veasey SC, Morgan BJ, O'Donnell CP. 2010. Pathophysiology of sleep apnea. Physiol Rev 90(1): 47-112.
14. Durán J, Esnaola S, Rubio R, Iztueta A. 2001. Obstructive sleep apnea-hypopnea and related clinical features in population-based sample of subjects aged 30-70 yr. Am J Respir Crit Care Med 163(3 Pt 1): 685-689.
15. Flemons WW, Tsai W. 1997. Quality of life consequences of sleep-disordered breathing. J Allergy Clin Immunol 99(2): S750-S756.
16. Garcia-Arocena D, Hagerman PJ. 2010. Advances in understanding the molecular basis of FXTAS. Hum Mol Genet 19(R1): R83-R89.
17. Gay P, Weaver T, Loube D, Iber C. 2006. Evaluation of positive airway pressure treatment for sleep related breathing disorders in adults. Sleep 29(3): 381-401.
18. Hagerman RJ, Leehey M, Heinrichs W, Tassone F, Wilson R, Hills J, Grigsby J, Gage B, Hagerman PJ. 2001. Intension tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 57(1): 127-130.
19. Hagerman RJ, Coffey SM, Maselli R, Soontarapornchai K, Brunberg JA, Leehey MA, Zhang L, Gane LW, Fenton-Farrell G, Tassone F, Hagerman PJ. 2007. Neuropathy as a presenting feature in fragile X-associated tremor/ataxia syndrome. Am J Med Genet Part A 143A(19): 2256-2260.
20. Jacquemont S, Hagerman RJ, Leehey M, Grigsby J, Zhang L, Brunberg JA, Greco C, Des Portes V, Jardini T, Levine R, Berry-Kravis E, Brown WT, Schaeffer S, Kissel J, Tassone F, Hagerman PJ. 2003. Fragile X premutation tremor/ataxia syndrome: Molecular, clinical, and neuroimaging correlates. Am J Hum Genet 72(4): 869-878.
21. Jacquemont S, Hagerman RJ, Leehey MA, Hall DA, Levine RA, Brunberg JA, Zhang L, Jardini T, Gane LW, Harris SW, Herman K, Grigsby J, Greco CM, Berry-Kravis E, Tassone F, Hagerman PJ. 2004. Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. JAMA 291(4): 460-469.
22. Jacquemont S, Hagerman RJ, Hagerman PJ, Leehey MA. 2007. Fragile-X syndrome and fragile X-associated tremor/ataxia syndrome: Two faces of FMR1. Lancet Neurol 6(1): 45-55.
23. Javaheri S. 2006. CPAP should not be used for central sleep apnea in congestive heart failure patients. J Clin Sleep Med 2(4): 399-402.
24. Kuzniar TJ, Morgenthaler TI, Prakash UB, Pallanch JF, Siber MH, Tippmann-Peikert M. 2009. Effects of continuous positive airway pressure on stidor in multiple system atrophy-sleep laryngoscopy. J Clin Sleep Med 5(1): 65-67.
25. Leehey MA, Berry-Kravis E, Min SJ, Hall DA, Rice CD, Zhang L, Grigsby J, Greco CM, Reynolds A, Lara R, Cogswell J, Jacquemont S, Hessl DR, Tassone F, Hagerman R, Hagerman PJ. 2007. Progression of tremor and ataxia in male carriers of the FMR1 premutation. Mov Disord 22(2): 203-206.
26. Madani M, Madani FM, Frank M. 2010. Psychological issues in sleep apnea. Oral Maxillofac Surg Clin North Am 22(4): 503-509.
27. Martinez-Garcia MA, Duran-Cantolla J, Montserrat JM. 2010. Sleep apnea-hypopnea syndrome in the elderly. Arch Bronconeumol 46(9): 479-488.
28. McNicholas WT. 2008. Diagnosis of obstructive sleep apnea in adults. Proc Am Thorac Soc 5: 154-160.
29. Mulgrew AT, Fox N, Ayas NT, Ryan CF. 2007. Diagnosis and initial management of obstructive sleep apnea without polysomnography: A randomized validation study. Ann Intern Med 146(3): 157-166.
30. Naismith SL, Lewis SJ, Rogers NL. 2011. Sleep-wake changes and cognition in neurodegenerative disease. Prog Brain Res 190: 21-52.
31. Noradina AT, Karim NA, Hamidon BB, Norlinah I, Raymond AA. 2010. Sleep-disordered breathing in patients with Parkinson's disease. Singapore Med J 51(1): 60-64.
32. O'Dwyer J, Clabby C, Crown D, Barton D, Hutchinson M. 2005. Fragile X-associated tremor/ataxia syndrome presenting in a woman after chemotherapy. Neurology 65(2): 331-332.
33. Paul R, Pessah I, Gane L, Ono M, Hagerman PJ, Brunberg JA, Tassone F, Bourgeois JA, Adams PE, Nguyen DV, Hagerman R. 2010. Early onset of neurological symptoms in fragile X premutation carriers exposed to neurotoxins. Neurotoxicology 31(4): 399-402.
34. Ross-Inta C, Omanska-Klusek A, Wong S, Barrow C, Garcia-Arocena D, Iwahashi C, Berry-Kravis E, Hagerman RJ, Hagerman PJ, Giulivi C. 2010. Evidence of mitochondrial dysfunction in fragile X-associated tremor/ataxia syndrome. Biochem J 429(3): 545-552.
35. Saluto A, Brussino A, Tassone F, Arduino C, Cagnoli C, Pappi P, Hagerman P, Migone N, Brusco A. 2005. An enhanced polymerase chain reaction assay to detect pre- and full mutation alleles of the fragile X mental retardation 1 gene. J Mol Diagn 7(5): 605-612.
36. Schulte EC, Winkelmann J. 2011. When Parkinson's disease patients go to sleep: Specific sleep disturbances related to Parkinson's disease. J Neurol 258(Suppl. 2): S328-S335.
37. Tassone F, Hagerman RJ, Taylor AK, Gane LW, Godfrey TE, Hagerman PJ. 2000. Elevated levels of FMR1 mRNA in carrier males: A new mechansim of involvment in the fragile-X syndrome. Am J Hum Genet 66(1): 6-15.
38. Tassone F, Iwahashi C, Hagerman PJ. 2004. FMR1 RNA within the intranuclear inclusions of fragile X-associated tremor/ataxia syndrome (FXTAS). RNA Biol 1(2): 103-105.
39. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. 1993. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328(17): 1230-1235.